Why Is Omicron A Superspreader? New Data Offers Clues
The omicron variant has been found to infect 70 times faster than the delta or original covid strain -- but causes less severe disease -- in a study from the University of Hong Kong. Why? Researchers observed that the virus takes stronger hold in the airways rather than the lungs.
NPR:
What Makes Omicron Spread So Quickly? A New Study Offers A Tantalizing Clue
Why is omicron such a superspreading variant? Preliminary data, published online Wednesday, gives us the first look at how omicron may behave inside the respiratory tract — and the data offers a tantalizing clue as to why this heavily mutated variant is spreading so fast and even outcompeting delta. The omicron variant multiplies about 70 times faster inside human respiratory tract tissue than the delta variant does, scientists at the University of Hong Kong report. The variant reaches also higher levels in the tissue, compared to delta, 48 hours after infection. (Doucleff, 12/15)
Reuters:
Omicron Thrives In Airways, Not Lungs; New Data On Asymptomatic Cases
Major differences in how efficiently Omicron and other variants of the coronavirus multiply may help predict Omicron's effects, researchers said on Wednesday. Compared to the earlier Delta variant, Omicron multiplies itself 70 times more quickly in tissues that line airway passages, which may facilitate person-to-person spread, they said. But in lung tissues, Omicron replicates 10 times more slowly than the original version of the coronavirus, which might contribute to less-severe illness. (Lapid, 12/16)
Bloomberg:
Omicron Infects 70 Times Faster But Is Less Severe, Study Says
The omicron variant infects around 70 times faster than delta and the original Covid-19 strain, though the severity of illness is likely to be much lower, according to a University of Hong Kong study that adds weight to the early on-ground observations from South African doctors. The supercharged speed of omicron’s spread in the human bronchus was found 24 hours following infection, according to a Wednesday statement from the university. The study, conducted by a team of researchers led by Michael Chan Chi-wai, found that the newest variant of concern replicated less efficiently -- more than 10 times lower -- in the human lung tissue than the original strain which may signal “lower severity of disease.” (Kay, 12/15)
